US to test experimental coronavirus vaccines in 100,000 people or more – Reuters

The United States is planning to test "half a dozen or so" of the most promising potential coronavirus vaccines with 100,000 to 150,000 volunteers, Re  |  22/05/2020 19:01

The United States is planning to test "half a dozen or so" of the most promising potential coronavirus vaccines with 100,000 to 150,000 volunteers, Reuters reported on Friday, citing scientists familiar with the matter.

The Oxford vaccine may be tested side by side with Moderna's vaccine starting in July, US health officials told Reuters. "Vaccines from J&J, Sanofi and Merck may be added this summer as they complete phase I safety studies."

Market reaction

This headline helped market sentiment improve during the American session. As of writing, the Nasdaq Composite was up 0.3% on the day while the S&P 500 was unchanged at 2,949 points.

Share

Popular News

Show More Popular News

Market Insight's Views

Market Insight analyses will provide both fundamental and technical comprehensions on finance
and other asset classes for Market Insight viewers

Back

Login to Market Insight Account

Your Market Insight account gives you access to the tools that we offer our customers including our
Technical Studies & Sentiment for your accounts.

Forgot Password?

Don't you have a Market Insight account? With a few easy steps you can easily register to Market Insight

Create a Market Insight's Account

Your Market Insight account gives you access to the tools that we offer our customers including our Technical Studies & Sentiment for your accounts.

register_ty

Thank you!

Welcome to Market Insight family!

You have succesfully completed the registration.
We will send you an e-mail to give you some
instructions and our Terms and Conditions!
Our account representatives will be contacting you as
soon as possible. If you have any further questions
please do not hesitate to mail us via info@marketinsight.com